Revista de la Sociedad Argentina de Diabetes (Nov 2020)

P53 Pharmacological diabetes approach in patients with solid organ transplantation

  • Yanina Jimena Morosan Allo,
  • Evelin Blanc,
  • Andrea Lorena Morejón Barragán,
  • Noelia Sforza,
  • Romina Clemente,
  • Claudia Folino,
  • Adrián Marcelo Pavasi,
  • Jimena Sabrina Santamaría,
  • María Gabriela Castillo,
  • Marcela Martínez,
  • Carla Musso

DOI
https://doi.org/10.47196/diab.v54i3Sup.439
Journal volume & issue
Vol. 54, no. 3Sup
pp. 158 – 158

Abstract

Read online

Background: Diabetes mellitus (DM) is a complication of solid organ transplantation and generally treated with insulin, recently new therapies have been implemented with good results. Objetive: We describe and evaluate pharmacological diabetes therapy in patients undergoing solid organ transplantation, as well as its impact on glucometabolic control. Method: This is an observational, retrospective study. We include solid organ transplantation patients with a post-transplant DM or pre-transplant DM diagnosis, who attended to a medical consultation between 7/2015 and 8/2019. Patients with less than 2 medical consultation in a period of 2 years were excluded. HbA1c levels and estimated glomerular filtration rate (eGFR) using the CKD-EPI equation were evaluated. The rate of change of immunosuppressive therapy and pharmacological diabetes therapy at 3, 6, 12, 18 and 24 months of follow-up was described. Statistical method: qualitative variables are described in absolute frequency / percentage and the quantitative variables in median / range according to their distribution. Nonparametric tests and Fisher's test were used to analyze differences.

Keywords